Gellan gum is unusual among food ingredients in that its entire history is documented and recent. It was not discovered in a laboratory by accident centuries ago, or extracted from a plant that people had been using for generations. It was found in a pond in the 1970s, characterised, patented, and commercialised — and the consequences of that origin are still visible in how the market is structured today.
1970s: a screening programme finds something new
The story begins with Kelco, a San Diego company specialising in microbial polysaccharides that had already commercialised xanthan gum. In an era when industrial research programmes screened environmental samples for microorganisms producing useful polymers, Kelco's scientists isolated a bacterium from the surface of Elodea canadensis — a common aquatic plant — collected from a pond in Pennsylvania.
The isolate produced an unusual polysaccharide. It was named S-60 internally, and the species epithet elodea was taken from the plant it was found on.
The organism was first classified as Pseudomonas elodea. Taxonomic revision later moved it to the genus Sphingomonas, giving the name used today: Sphingomonas elodea.
The collected strain became ATCC 31461, and every commercial gellan gum produced anywhere in the world descends from that lineage.
Early 1980s: structure, patents and a first market
Two developments in the early 1980s turned a laboratory curiosity into a product.
The structure was solved. Gellan gum's repeating unit — two glucose residues, one glucuronic acid and one rhamnose — was characterised, along with the two acyl substituents that decorate the backbone. That structural work is the foundation of everything in this knowledge base: it explains why the polymer gels, why cations matter, and why removing the acyl groups changes the texture so dramatically.
Patents were filed. A foundational US patent on the heteropolysaccharide and its preparation issued in the early 1980s. Patent protection is a theme that runs through the ingredient's entire commercial history, and it is still running today — see the 2026 EPO decision covered elsewhere on this site.
The first commercial application was not food. Gellan gum was adopted initially for microbiological culture media and plant tissue culture, under the brand names Gelrite and Phytagel. This is a revealing detail. In a laboratory, the advantage of a gellan gum gel is obvious and immediate: it is transparent, it can be used at a much lower concentration than agar, and its high melting temperature means the gel stays firm in a warm incubator. Those same properties took years to become commercially valuable in food, where established ingredients already worked.
1988: Japan approves it for food
Japan became the first market to approve gellan gum for food use, in 1988. The country's food industry was an early adopter, and the timing is instructive — Japan was also early in adopting other fermentation-derived hydrocolloids.
1990s: the United States, the European Union, and a pharmaceutical career
1992 — United States. Gellan gum was authorised as a direct food additive under 21 CFR 172.665. At the time it was reported as the first genuinely new hydrocolloid approved for food use in the United States in decades, which is why the approval was notable beyond the ingredient itself.
Early 1990s — pharmaceutical. The in-situ gelling property found a pharmaceutical application in ophthalmic formulation: eye drops containing gellan gum remain liquid in the bottle and gel in contact with the calcium in the tear film. A timolol maleate ophthalmic gel-forming solution based on the polymer reached the market in the early 1990s, and the technology remains a textbook example of ion-triggered gelation.
1990s — European Union. Gellan gum entered the EU framework as E 418, initially evaluated by the Scientific Committee for Food in 1990 with the opinion published in 1992, and allocated an ADI "not specified". The Commission later defined specific purity criteria, now found in Commission Regulation (EU) No 231/2012.
2000s: scale, competition and price
Two shifts changed the commercial landscape in the 2000s.
Production moved east. Chinese fermentation capacity expanded significantly. Gellan gum requires the same core competencies as other fermentation products — strain handling, sterile operation, downstream separation — and those capabilities were being built at scale in China across many ingredients.
Prices came down. A single-origin, patent-protected specialty became a competitive market. For buyers, the practical consequence was a genuine choice of suppliers, accompanied by the quality-consistency problem that still defines the market: materials that meet the same specification can differ in molecular weight, acyl content and residual activity.
Applications broadened. Gellan gum moved from a niche texturiser into mainstream beverage suspension, driven by the growth of products that needed particles held in a thin liquid — pulpy juices, calcium-fortified drinks, and eventually plant-based milks.
2010s: plant-based drinks and the clean-label decade
The 2010s were when gellan gum became a mainstream ingredient in Western markets, for a reason that had nothing to do with the gum itself: the plant-based beverage boom.
Plant-based milks and protein drinks have a hard formulation problem. They carry minerals and protein that settle, and consumers expect them to pour like milk. Gellan gum solved it at 0.02–0.05 %, and demand grew with the category.
Two parallel trends reinforced the position:
- Clean label and gelatin replacement. Vegan gummies and desserts needed a structuring agent with a non-animal origin, and gellan gum's fermentation route made it easy to position.
- Re-evaluation and data. The 2018 EFSA re-evaluation applied current risk-assessment methods to E 418 and concluded that no numerical ADI was needed, while recommending better specification of PHB, protein and residual enzymatic activity. That recommendation is still driving which parameters buyers now ask for.
2020s: a mature ingredient with an open patent landscape
The current decade looks different from the last one in three ways:
- Consolidation and specialisation. The supply base has settled into a small number of large producers and a longer tail of specialists, with documentation quality as the main differentiator.
- Regulatory tightening. Residue limits, ETO testing and documentation expectations have all increased, particularly in Europe.
- Patent expiry. Key process patents have expired or been revoked, opening the door to new producers. The 2026 EPO decision revoking a fermentation patent in this area is the most recent chapter — see our article on what that decision means.
Why the history matters
Three takeaways for anyone working with the ingredient today:
- The single-strain origin explains the market's structure. One organism, a handful of producers, and a high barrier to entry in downstream processing.
- The applications came in a revealing order. Tissue culture first, then food, then beverages, then pharmaceuticals — each one exploiting the same two properties: clarity and low-dosage gelation.
- The regulatory file is short and readable. Gellan gum's entire safety history fits in a handful of documents. There is no shortage of data to work from — only a shortage of people who read the originals. Start with the EFSA opinion and the JECFA monograph, and work forward.
For specification data and technical documentation on gellan gum (E418), contact Cinogel.
Part of the E418.org gellan gum knowledge base. See also: what is gellan gum, and gellan gum fermentation patent revoked by the EPO.